Corrina M.A. de Ridder

Corrina M.A. de Ridder is a Researcher affiliated with the Erasmus University Medical Center (Erasmus MC) in the Department of Urology. Her primary research focuses on pharmacology, toxicology, and pharmaceutical science, with specialized expertise in prostate cancer, radionuclide therapy, and molecular targeting of tumors. She actively contributes to translational oncology research through innovative therapeutic approaches.

Her scientific investigations span multiple cancer domains, including prostate carcinoma, neuroendocrine tumors, and pancreatic ductal adenocarcinoma. Key research themes involve developing novel theranostic agents, optimizing radionuclide therapies using isotopes like Lutetium-177 and Terbium-161, and evaluating drug conjugates for targeted cancer treatment. She employs diverse methodologies from molecular pharmacology to whole-body imaging techniques.

Recent publication trends demonstrate her focus on advancing cancer theranostics, including comparative studies of radioisotopes, development of small-molecule drug conjugates, and assessment of photosensitizer efficacy. Her work frequently incorporates both in vitro and in vivo models to validate therapeutic approaches before clinical translation.

No information is available regarding awards, student mentorship, research grants, or laboratory affiliations in the provided text.